Correspondence Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies

被引：15
|
作者：
Maglione, Alessandro [1 ]
Morra, Marta [1 ]
Meroni, Raffaella [1 ]
Matta, Manuela [1 ]
Clerico, Marinella [1 ]
Rolla, Simona [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2022年 / 61卷
关键词：
Multiple sclerosis; Anti-SARS-Cov2; vaccine; Booster; Third dose;
D O I：
10.1016/j.msard.2022.103776
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Anti-SARS-CoV2 mRNA vaccines showed a blunted antibody (Ab) response in people with MS (pwMS) on high efficacy therapies, suggesting the need for a booster dose. We evaluated the kinetics of the production of antireceptor binding domain (RBD) Immunoglobulins G (IgG) after the vaccination cycle and the booster in pwMS receiving ocrelizumab, fingolimod and cladribine. A significant increase of anti-RBD IgG seroconversion was observed after booster respect to the vaccination cycle. Results obtained from this study will be useful for the management of pwMS in relation to their disease modifying therapy (DMT) and for any future vaccination campaign.
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
    Salvagno, G. L.
    Henry, B. M.
    Lippi, G.
    INFECTIOUS DISEASES NOW, 2022, 52 (06): : 379 - 380
  • [22] Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
    Hamzavi, Seyedeh Sadigheh
    Bahrololoom, Rosemina
    Saeb, Sepideh
    Marandi, Nahid Heydari
    Hosseini, Marzieh
    Abadi, Alimohammad Keshtvarz Hesam
    Jamalidoust, Marzieh
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [23] Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
    Dalu, Davide
    Tarkowski, Maciej
    Ruggieri, Lorenzo
    Cona, Maria Silvia
    Gabrieli, Arianna
    De Francesco, Davide
    Fasola, Cinzia
    Ferrario, Sabrina
    Gambaro, Anna
    Masedu, Elsa
    Parma, Gaia
    Rulli, Eliana
    De Stradis, Claudia
    Mavilio, Domenico
    Calcaterra, Francesca
    Manoni, Federica
    Riva, Agostino
    La Verde, Nicla
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (08) : 1371 - 1376
  • [24] Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?
    Jeantin, Lina
    Abdi, Basma
    Soulie, Cathia
    Sterlin, Delphine
    Maillart, Elisabeth
    Beigneux, Ysoline
    Hippolyte, Amandine
    Belin, Lisa
    Marcelin, Anne-Genevieve
    Pourcher, Valerie
    Louapre, Celine
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (01) : 19 - 28
  • [25] Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
    Pereira, Rosa M. R.
    Dagostin, Marilia A.
    Caparbo, Valeria F.
    Sales, Lucas P.
    Pasoto, Sandra G.
    Silva, Clovis A.
    Yuki, Emily F. N.
    Saad, Carla G. S.
    Medeiros-Ribeiro, Ana C.
    Kupa, Leonard V. K.
    Fusco, Solange R. G.
    Martins, Victor A. O.
    Martins, Carolina C. M. F.
    Barbas, Carmen Valente
    Shinjo, Samuel K.
    Aikawa, Nadia E.
    Bonfa, Eloisa
    CLINICS, 2023, 78
  • [26] Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
    Picchianti-Diamanti, Andrea
    Navarra, Assunta
    Aiello, Alessandra
    Lagana, Bruno
    Cuzzi, Gilda
    Salmi, Andrea
    Vanini, Valentina
    Maggi, Fabrizio
    Meschi, Silvia
    Matusali, Giulia
    Notari, Stefania
    Agrati, Chiara
    Salemi, Simonetta
    Di Rosa, Roberta
    Passarini, Damiano
    Di Gioia, Valeria
    Sesti, Giorgio
    Conti, Fabrizio
    Spinelli, Francesca Romana
    Corpolongo, Angela
    Chimenti, Maria Sole
    Ferraioli, Mario
    Sebastiani, Gian Domenico
    Benucci, Maurizio
    Li Gobbi, Francesca
    Santoro, Anna Paola
    Capri, Andrea
    Puro, Vincenzo
    Nicastri, Emanuele
    Goletti, Delia
    VACCINES, 2023, 11 (11)
  • [27] Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
    Bellinvia, Angelo
    Aprea, Maria Grazia
    Portaccio, Emilio
    Pasto, Luisa
    Razzolini, Lorenzo
    Fonderico, Mattia
    Addazio, Ilaria
    Betti, Matteo
    Amato, Maria Pia
    NEUROLOGICAL SCIENCES, 2022, 43 (10) : 5783 - 5794
  • [28] Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study
    Ladeira, Filipa
    Nobrega, Claudia
    Cerqueira, Joao
    COVACiMS Collaborators, Carlos
    JOURNAL OF NEUROLOGY, 2025, 272 (04)
  • [29] Hypogammaglobulinemia is associated with reduced antibody response after anti-SARS-CoV-2 vaccination in MS patients treated with antiCD20 therapies
    Angelo Bellinvia
    Maria Grazia Aprea
    Emilio Portaccio
    Luisa Pastò
    Lorenzo Razzolini
    Mattia Fonderico
    Ilaria Addazio
    Matteo Betti
    Maria Pia Amato
    Neurological Sciences, 2022, 43 : 5783 - 5794
  • [30] Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
    Hernandez-Porto, Miriam
    Garcia, Sagrario
    Delgado, Teresa
    Rodriguez, Yaiza
    Aguirre-Jaime, Armando
    Campos, Silvia
    Hernandez, Cintia
    Lorenzo, Carmen
    Lecuona, Maria
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 327 - 331
12345